Clinical Trial Update: A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Oral Ciprofloxacin in the Treatment of Adults With Uncomplicated Infections of the Skin and the Supportive Layers Beneath the Skin [Phase 3]

View source ↗

Summary

A Phase 3 randomized study comparing oral levofloxacin to oral ciprofloxacin in adults with uncomplicated skin and soft tissue infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin and Soft Tissue Infections

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Skin Diseases, Infectious | Phase 3 | Status: COMPLETED